Transaction includes transfer of OraSure’s professional Histofreezer product line and several private label cryosurgical products sold in the consumer market.
Virtue SEB is expected to become a flagship therapeutic product for Terumo and will strengthen its U.S. and global portfolio of interventional solutions.